{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T08:29:14Z","timestamp":1790152154831,"version":"4.0.1"},"reference-count":178,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T00:00:00Z","timestamp":1636329600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Acute-on-chronic liver failure (ACLF) is a multifaceted condition with poor treatment options and high short-term mortality. ACLF can develop in patients with or without liver cirrhosis, where patients with decompensated cirrhosis display a higher risk of short-term mortality. Pathophysiological mechanisms include systemic inflammation due to bacterial and fungal infections and acute hepatic insult with drug, alcohol, and viral hepatitis. Cryptogenic factors also contribute to the development of ACLF. The clinical outcome of patients with ACLF gets further complicated by the occurrence of variceal hemorrhage, hepatorenal syndrome, hepatic encephalopathy, and systemic immune dysfunction. Regardless of the better understanding of pathophysiological mechanisms, no specific and definitive treatment is available except for liver transplantation. The recent approach of regenerative medicine using mesenchymal stem cells (MSCs) could be advantageous for the treatment of ACLF as these cells can downregulate inflammatory response by inducing antiinflammatory events and prevent hepatic damage and fibrosis by inhibiting hepatic stellate cell activation and collagen synthesis. Moreover, MSCs are involved in tissue repair by the process of liver regeneration. Considering the broad therapeutic potential of MSCs, it can serve as an alternative treatment to liver transplant in the near future, if promising results are achieved.<\/jats:p>","DOI":"10.3389\/fmed.2021.752875","type":"journal-article","created":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T05:00:46Z","timestamp":1636347646000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":50,"title":["Acute-on-Chronic Liver Failure: Pathophysiological Mechanisms and Management"],"prefix":"10.3389","volume":"8","author":[{"given":"Arshi","family":"Khanam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyam","family":"Kottilil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,11,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1053\/j.gastro.2013.02.042","article-title":"Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis","volume":"144","author":"Moreau","year":"2013","journal-title":"Gastroenterology."},{"key":"B2","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s12072-014-9580-2","article-title":"Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL)","volume":"8","author":"Sarin","year":"2014","journal-title":"Hepatol Int."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1002\/hep.30494","article-title":"Incidence and mortality of acute-on-chronic liver failure using two definitions in patients with compensated cirrhosis","volume":"69","author":"Mahmud","year":"2019","journal-title":"Hepatology."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1002\/hep.29773","article-title":"NACSELD acute-on-chronic liver failure (NACSELD-ACLF) score predicts 30-day survival in hospitalized patients with cirrhosis","volume":"67","author":"O'Leary","year":"2018","journal-title":"Hepatology."},{"key":"B5","doi-asserted-by":"publisher","first-page":"3448","DOI":"10.3748\/wjg.v17.i29.3448","article-title":"Survival and prognostic factors in hepatitis B virus-related acute-on-chronic liver failure","volume":"17","author":"Huang","year":"2011","journal-title":"World J Gastroenterol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.dld.2011.08.029","article-title":"Clinical profile and predictors of mortality in patients of acute-on-chronic liver failure","volume":"44","author":"Garg","year":"2012","journal-title":"Dig Liver Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1186\/s12916-020-01814-4","article-title":"The efficacy and safety of methylprednisolone in hepatitis B virus-related acute-on-chronic liver failure: a prospective multi-center clinical trial","volume":"18","author":"Jia","year":"2020","journal-title":"BMC Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1097\/MCC.0b013e328344a076","article-title":"Acute-on-chronic liver failure: the liver and portal haemodynamics","volume":"17","author":"Mookerjee","year":"2011","journal-title":"Curr Opin Crit Care."},{"key":"B9","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1111\/liv.12559","article-title":"Systemic inflammation is associated with increased intrahepatic resistance and mortality in alcohol-related acute-on-chronic liver failure","volume":"35","author":"Mehta","year":"2015","journal-title":"Liver Int."},{"key":"B10","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3350\/cmh.2019.0011","article-title":"The fibrogenic process and the unleashing of acute-on-chronic liver failure","volume":"26","author":"L\u00f3pez-S\u00e1nchez","year":"2020","journal-title":"Clin Mol Hepatol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"16041","DOI":"10.1038\/nrdp.2016.41","article-title":"Acute-on-chronic liver failure in cirrhosis","volume":"2","author":"Arroyo","year":"2016","journal-title":"Nat Rev Dis Primers."},{"key":"B12","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1478-3231.2011.02517.x","article-title":"All-cause mortality in people with cirrhosis compared with the general population: a population-based cohort study","volume":"32","author":"Fleming","year":"2012","journal-title":"Liver Int."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.3390\/cells9122632","article-title":"Leukocytes, systemic inflammation and immunopathology in acute-on-chronic liver failure","volume":"9","author":"Casulleras","year":"2020","journal-title":"Cells."},{"key":"B14","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.jhep.2020.11.048","article-title":"The systemic inflammation hypothesis: towards a new paradigm of acute decompensation and multiorgan failure in cirrhosis","volume":"74","author":"Arroyo","year":"2021","journal-title":"J Hepatol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.3389\/fimmu.2020.02013","article-title":"Abnormal innate immunity in acute-on-chronic liver failure: immunotargets for therapeutics","volume":"11","author":"Khanam","year":"2020","journal-title":"Front Immunol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"464","DOI":"10.3389\/fimmu.2017.00464","article-title":"Blockade of neutrophil's chemokine receptors CXCR1\/2 abrogate liver damage in acute-on-chronic liver failure","volume":"8","author":"Khanam","year":"2017","journal-title":"Front Immunol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1007\/s12072-014-9538-4","article-title":"Growth factors enhance liver regeneration in acute-on-chronic liver failure","volume":"8","author":"Kedarisetty","year":"2014","journal-title":"Hepatol Int."},{"key":"B18","article-title":"Chemokine ligand CXCL-8 mediated activation and neutrophil influx aggravates liver injury and correlates with clinical severity indices in acute-on-chronic liver failure (ACLF):283","volume":"58","author":"Khanam","year":"2013","journal-title":"Hepatology."},{"key":"B19","article-title":"High CXCR-1 and CXCR-2 expressing neutrophils induce early hepatocyte death and promote liver injury in acute-on-chronic liver failure: 1762","volume":"62","author":"Khanam","year":"2015","journal-title":"Hepatology."},{"key":"B20","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12967-019-1844-0","article-title":"Altered PGE2-EP2 is associated with an excessive immune response in HBV-related acute-on-chronic liver failure","volume":"17","author":"Wang","year":"2019","journal-title":"J Transl Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"4773","DOI":"10.12659\/MSM.915637","article-title":"Microbial infections as a trigger for acute-on-chronic liver failure: a review","volume":"25","author":"Cai","year":"2019","journal-title":"Med Sci Monit."},{"key":"B22","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.jhep.2018.12.008","article-title":"Acute-on-chronic liver failure in patients with alcohol-related liver disease","volume":"70","author":"Gustot","year":"2019","journal-title":"J Hepatol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e0250062","DOI":"10.1371\/journal.pone.0250062","article-title":"Vulnerability to recurrent episodes of acute decompensation\/acute-on-chronic liver failure characterizes those triggered by indeterminate precipitants in patients with liver cirrhosis","volume":"16","author":"Hoshi","year":"2021","journal-title":"PLoS ONE."},{"key":"B24","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1136\/gutjnl-2016-312670","article-title":"Acute-on-chronic liver failure: an update","volume":"66","author":"Hernaez","year":"2017","journal-title":"Gut."},{"key":"B25","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nrgastro.2015.219","article-title":"Acute-on-chronic liver failure: terminology, mechanisms and management","volume":"13","author":"Sarin","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"3755","DOI":"10.4049\/jimmunol.1600818","article-title":"The acute-on-chronic liver failure syndrome, or when the innate immune system goes astray","volume":"197","author":"Claria","year":"2016","journal-title":"J Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.1111\/liv.12850","article-title":"Mechanism of cell death in acute-on-chronic liver failure: a clinico-pathologic-biomarker study","volume":"35","author":"Adebayo","year":"2015","journal-title":"Liver Int."},{"key":"B28","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12876-019-1064-3","article-title":"The different expression of caspase-1 in HBV-related liver disease and acts as a biomarker for acute-on-chronic liver failure","volume":"19","author":"Zhang","year":"2019","journal-title":"BMC Gastroenterol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1111\/jvh.13100","article-title":"Serum keratin-18 fragments as cell death biomarker in association with disease progression and prognosis in hepatitis B virus-related cirrhosis","volume":"26","author":"Cao","year":"2019","journal-title":"J Viral Hepat."},{"key":"B30","doi-asserted-by":"publisher","first-page":"14240","DOI":"10.1038\/srep14240","article-title":"Circulating cell death biomarker: good candidates of prognostic indicator for patients with hepatitis B virus related acute-on-chronic liver failure","volume":"5","author":"Cao","year":"2015","journal-title":"Sci Rep."},{"key":"B31","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1089\/jir.2015.0166","article-title":"Natural killer group 2A expressed on both peripheral CD3(-)CD56(+)NK cells and CD3(+)CD8(+)T cells plays a pivotal negative regulatory role in the progression of hepatitis B virus-related acute-on-chronic liver failure","volume":"36","author":"Yi","year":"2016","journal-title":"J Interferon Cytok Res."},{"key":"B32","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1111\/liv.12415","article-title":"Altered frequencies of dendritic cells and IFN-gamma-secreting T cells with granulocyte colony-stimulating factor (G-CSF) therapy in acute-on- chronic liver failure","volume":"34","author":"Khanam","year":"2014","journal-title":"Liver Int."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1111\/liv.14015","article-title":"Increased interleukin-23 receptor (IL-23R) expression is associated with disease severity in acute-on-chronic liver failure","volume":"39","author":"Khanam","year":"2019","journal-title":"Liver Int."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1002\/jmv.25466","article-title":"Myeloid-derived suppressor cells expansion is closely associated with disease severity and progression in HBV-related acute-on-chronic liver failure","volume":"91","author":"Zeng","year":"2019","journal-title":"J Med Virol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1055\/s-0036-1583199","article-title":"The pathogenesis of ACLF: the inflammatory response and immune function","volume":"36","author":"Moreau","year":"2016","journal-title":"Semin Liver Dis."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(16)00878-3","article-title":"Neutrophils induce early hepatocyte death by contact dependent and independent mechanisms and positively correlate with the disease outcome in acute-on-chronic liver failure","volume":"64","author":"Khanam","year":"2016","journal-title":"Journal of Hepatology."},{"key":"B37","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1007\/s10753-012-9525-7","article-title":"Intrahepatic expression of programmed death-1 and its ligands in patients with HBV-related acute-on-chronic liver failure","volume":"36","author":"Cao","year":"2013","journal-title":"Inflammation."},{"key":"B38","doi-asserted-by":"publisher","first-page":"534731","DOI":"10.3389\/fimmu.2020.534731","article-title":"Dysregulated adaptive immunity is an early event in liver cirrhosis preceding acute-on-chronic liver failure","volume":"11","author":"Rueschenbaum","year":"2020","journal-title":"Front Immunol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1111\/liv.14392","article-title":"Genetic variants of innate immunity receptors are associated with mortality in cirrhotic patients with bacterial infection","volume":"40","author":"Schaapman","year":"2020","journal-title":"Liver Int."},{"key":"B40","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1002\/hep.28896","article-title":"Polymorphisms in the IL-1 gene cluster influence systemic inflammation in patients at risk for acute-on-chronic liver failure","volume":"65","author":"Alcaraz-Quiles","year":"2017","journal-title":"Hepatology."},{"key":"B41","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1159\/000488690","article-title":"Immunodysfunction in acute-on-chronic liver failure","volume":"34","author":"Lange","year":"2018","journal-title":"Visc Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1053\/j.gastro.2014.11.045","article-title":"Patients with acute-on-chronic liver failure have increased numbers of regulatory immune cells expressing the receptor tyrosine kinase MERTK","volume":"148","author":"Bernsmeier","year":"2015","journal-title":"Gastroenterology."},{"key":"B43","article-title":"Increased expression of regulatory T cells in liver ineffective in downregulating the inflammatory activation of T cells in acute on chronic liver failure (ACLF):1643","volume":"52","author":"Khanam","year":"2010","journal-title":"Hepatology."},{"key":"B44","doi-asserted-by":"publisher","first-page":"973","DOI":"10.3389\/fimmu.2019.00973","article-title":"Dysfunctional Immune response in acute-on-chronic liver failure: it takes two to Tango","volume":"10","author":"Martin-Mateos","year":"2019","journal-title":"Front Immunol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1053\/j.gastro.2014.11.041","article-title":"Blockade of PD1 and TIM3 restores innate and adaptive immunity in patients with acute alcoholic hepatitis","volume":"148","author":"Markwick","year":"2015","journal-title":"Gastroenterology."},{"key":"B46","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jhep.2004.10.019","article-title":"Patients with acute on chronic liver failure display \u201csepsis-like\u201d immune paralysis","volume":"42","author":"Wasmuth","year":"2005","journal-title":"J Hepatol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"2948","DOI":"10.3389\/fimmu.2018.02948","article-title":"The role of monocytes and macrophages in acute and acute-on-chronic liver failure","volume":"9","author":"Triantafyllou","year":"2018","journal-title":"Front Immunol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1136\/gutjnl-2017-314184","article-title":"CD14(+) CD15(-) HLA-DR(-) myeloid-derived suppressor cells impair antimicrobial responses in patients with acute-on-chronic liver failure","volume":"67","author":"Bernsmeier","year":"2018","journal-title":"Gut."},{"key":"B49","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1159\/000491107","article-title":"Management of infectious complications associated with acute-on-chronic liver failure","volume":"34","author":"Engelmann","year":"2018","journal-title":"Visceral Med."},{"key":"B50","doi-asserted-by":"publisher","first-page":"97","DOI":"10.2147\/HMER.S197933","article-title":"Severe alcoholic hepatitis: current perspectives","volume":"11","author":"Philips","year":"2019","journal-title":"Hepat Med."},{"key":"B51","first-page":"163","article-title":"Alcohol and gut-derived inflammation","volume":"38","author":"Bishehsari","year":"2017","journal-title":"Alcohol Res."},{"key":"B52","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/s41575-018-0099-1","article-title":"Alcohol, liver disease and the gut microbiota","volume":"16","author":"Bajaj","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"B53","first-page":"237","article-title":"The role of innate immunity in alcoholic liver disease","volume":"37","author":"Nagy","year":"2015","journal-title":"Alcohol Res Curr Rev."},{"key":"B54","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.jcmgh.2015.04.003","article-title":"The gut microbiota and liver disease","volume":"1","author":"Llorente","year":"2015","journal-title":"Cell Mol Gastroenterol Hepatol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"8082","DOI":"10.3748\/wjg.v20.i25.8082","article-title":"Oxidative stress as a crucial factor in liver diseases","volume":"20","author":"Cichoz-Lach","year":"2014","journal-title":"World J Gastroenterol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1136\/gutjnl-2014-308410","article-title":"Progenitor cell expansion and impaired hepatocyte regeneration in explanted livers from alcoholic hepatitis","volume":"64","author":"Dubuquoy","year":"2015","journal-title":"Gut."},{"key":"B57","first-page":"279","article-title":"Prenatal alcohol exposure and the developing immune system","volume":"37","author":"Gauthier","year":"2015","journal-title":"Alcohol Res Curr Rev."},{"key":"B58","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1111\/j.1365-2893.2009.01254.x","article-title":"Hepatitis B virus genotype and basal core promoter\/precore mutations are associated with hepatitis B-related acute-on-chronic liver failure without pre-existing liver cirrhosis","volume":"17","author":"Ren","year":"2010","journal-title":"J Viral Hepat."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1053\/j.gastro.2011.12.061","article-title":"Epidemiology of viral hepatitis and hepatocellular carcinoma","volume":"142","author":"El-Serag","year":"2012","journal-title":"Gastroenterology."},{"key":"B60","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1186\/s12879-019-3988-1","article-title":"Is HBV viral load at admission associated with development of acute-on-chronic liver failure in patients with acute decompensation of chronic hepatitis B related cirrhosis?","volume":"19","author":"Lei","year":"2019","journal-title":"BMC Infect Dis."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1053\/j.gastro.2017.02.009","article-title":"Hepatitis B reactivation associated with immune suppressive and biological modifier therapies: current concepts, management strategies, and future directions","volume":"152","author":"Loomba","year":"2017","journal-title":"Gastroenterology."},{"key":"B62","doi-asserted-by":"publisher","first-page":"3953","DOI":"10.3748\/wjg.v21.i13.3953","article-title":"Differentiation of acute and chronic hepatitis B in IgM anti-HBc positive patients","volume":"21","author":"Park","year":"2015","journal-title":"World J Gastroenterol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1002\/jmv.20661","article-title":"Basal core promoter, precore region mutations of HBV and their association with e antigen, genotype, and severity of liver disease in patients with chronic hepatitis B in India","volume":"78","author":"Chauhan","year":"2006","journal-title":"J Med Virol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jhep.2015.01.029","article-title":"Submassive hepatic necrosis distinguishes HBV-associated acute on chronic liver failure from cirrhotic patients with acute decompensation","volume":"63","author":"Li","year":"2015","journal-title":"J Hepatol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.jhep.2018.12.018","article-title":"Prevalence and short-term mortality of acute-on-chronic liver failure: a national cohort study from the USA","volume":"70","author":"Hernaez","year":"2019","journal-title":"J Hepatol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1172\/JCI130197","article-title":"Plasminogen as a prognostic biomarker for HBV-related acute-on-chronic liver failure","volume":"130","author":"Wu","year":"2020","journal-title":"J Clin Invest."},{"key":"B67","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.jceh.2013.08.013","article-title":"Hepatitis E and acute-on-chronic liver failure","volume":"3","author":"Kumar","year":"2013","journal-title":"J Clin Exp Hepatol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s12072-010-9204-4","article-title":"Comparison of effects of hepatitis E or A viral superinfection in patients with chronic hepatitis B","volume":"4","author":"Zhang","year":"2010","journal-title":"Hepatol Int."},{"key":"B69","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1111\/j.1478-3231.2008.01887.x","article-title":"Clinical features and predictors of outcome in acute hepatitis A and hepatitis E virus hepatitis on cirrhosis","volume":"29","author":"Radha Krishna","year":"2009","journal-title":"Liver Int."},{"key":"B70","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1111\/liv.12114","article-title":"Ribavirin treatment of acute and chronic hepatitis E: a single-centre experience","volume":"33","author":"Pischke","year":"2013","journal-title":"Liver Int."},{"key":"B71","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1097\/QCO.0000000000000316","article-title":"Treatment of hepatitis E virus","volume":"29","author":"Dalton","year":"2016","journal-title":"Curr Opin Infect Dis."},{"key":"B72","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","article-title":"EASL Clinical Practice Guidelines: autoimmune hepatitis","volume":"63","year":"2015","journal-title":"J Hepatol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.jhep.2014.05.021","article-title":"Prognosis of acute severe autoimmune hepatitis (AS-AIH): the role of corticosteroids in modifying outcome","volume":"61","author":"Yeoman","year":"2014","journal-title":"J Hepatol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1002\/hep.30205","article-title":"Flare of autoimmune hepatitis causing acute on chronic liver failure: diagnosis and response to corticosteroid therapy","volume":"70","author":"Anand","year":"2019","journal-title":"Hepatology."},{"key":"B75","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s12072-019-09946-3","article-title":"Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update","volume":"13","author":"Sarin","year":"2019","journal-title":"Hepatol Int."},{"key":"B76","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.jhep.2018.08.009","article-title":"EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis","volume":"69","year":"2018","journal-title":"J Hepatol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1111\/liv.13589","article-title":"The pathophysiology of arterial vasodilatation and hyperdynamic circulation in cirrhosis","volume":"38","author":"Moller","year":"2018","journal-title":"Liver Int."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1111\/jgh.12191","article-title":"Hepatic and systemic hemodynamic derangements predict early mortality and recovery in patients with acute-on-chronic liver failure","volume":"28","author":"Garg","year":"2013","journal-title":"J Gastroenterol Hepatol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/j.jhep.2020.04.024","article-title":"Rebleeding and mortality risk are increased by ACLF but reduced by pre-emptive TIPS","volume":"73","author":"Trebicka","year":"2020","journal-title":"J Hepatol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"s60","DOI":"10.7861\/clinmedicine.18-2-s60","article-title":"Management of decompensated cirrhosis","volume":"18","author":"Mansour","year":"2018","journal-title":"Clin Med."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7555\/JBR.31.20160060","article-title":"Acute-on-chronic liver failure: recent update","volume":"31","author":"Alam","year":"2017","journal-title":"J Biomed Res."},{"key":"B82","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.jhep.2014.09.005","article-title":"Hepatic encephalopathy in patients with acute decompensation of cirrhosis and acute-on-chronic liver failure","volume":"62","author":"Romero-Gomez","year":"2015","journal-title":"J Hepatol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/clpt.2012.112","article-title":"Ammonia-lowering strategies for the treatment of hepatic encephalopathy","volume":"92","author":"Rose","year":"2012","journal-title":"Clin Pharmacol Therapeut."},{"key":"B84","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S1665-2681(19)31785-5","article-title":"Hepatic encephalopathy, ammonia, glutamate, glutamine and oxidative stress","volume":"8","author":"Lemberg","year":"2009","journal-title":"Ann Hepatol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.jhep.2020.10.004","article-title":"Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality","volume":"74","author":"Costa","year":"2021","journal-title":"J Hepatol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jhepr.2019.02.005","article-title":"Acute-on-chronic liver failure: objective admission and support criteria in the intensive care unit","volume":"1","author":"Dong","year":"2019","journal-title":"JHEP Rep."},{"key":"B87","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.mayocp.2013.11.009","article-title":"Management of hepatic encephalopathy in the hospital","volume":"89","author":"Leise","year":"2014","journal-title":"Mayo Clin Proc."},{"key":"B88","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1097\/MEG.0000000000001311","article-title":"Long-term management of hepatic encephalopathy with lactulose and\/or rifaximin: a review of the evidence","volume":"31","author":"Hudson","year":"2019","journal-title":"Eur J Gastroenterol Hepatol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s11011-013-9383-5","article-title":"Antibiotics for the treatment of hepatic encephalopathy","volume":"28","author":"Patidar","year":"2013","journal-title":"Metab Brain Dis."},{"key":"B90","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1345\/aph.1R146","article-title":"Combination therapy for the treatment and prevention of hepatic encephalopathy","volume":"46","author":"Mohammad","year":"2012","journal-title":"Ann Pharmacother."},{"key":"B91","doi-asserted-by":"publisher","first-page":"480309","DOI":"10.1155\/2012\/480309","article-title":"A current review of the diagnostic and treatment strategies of hepatic encephalopathy","volume":"2012","author":"Poh","year":"2012","journal-title":"Int J Hepatol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1055\/s-0038-1657751","article-title":"Bacterial infections in acute-on-chronic liver failure","volume":"38","author":"Yang","year":"2018","journal-title":"Semin Liver Dis."},{"key":"B93","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1136\/gutjnl-2017-314240","article-title":"Bacterial and fungal infections in acute-on-chronic liver failure: prevalence, characteristics and impact on prognosis","volume":"67","author":"Fernandez","year":"2018","journal-title":"Gut."},{"key":"B94","doi-asserted-by":"publisher","first-page":"158","DOI":"10.4254\/wjh.v4.i5.158","article-title":"Bacterial infections other than spontaneous bacterial peritonitis in cirrhosis","volume":"4","author":"Bunchorntavakul","year":"2012","journal-title":"World J Hepatol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"307","DOI":"10.4254\/wjh.v8.i6.307","article-title":"Bacterial infections in cirrhosis: a critical review and practical guidance","volume":"8","author":"Bunchorntavakul","year":"2016","journal-title":"World J Hepatol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.jhep.2016.08.006","article-title":"The challenges of multi-drug-resistance in hepatology","volume":"65","author":"Fern\u00e1ndez","year":"2016","journal-title":"J Hepatol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1086\/317494","article-title":"Population-based study of the risk and short-term prognosis for bacteremia in patients with liver cirrhosis","volume":"31","author":"Thulstrup","year":"2000","journal-title":"Clin Infect Dis."},{"key":"B98","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1186\/s12876-020-01473-y","article-title":"Infection deteriorating hepatitis B virus related acute-on-chronic liver failure: a retrospective cohort study","volume":"20","author":"Zhai","year":"2020","journal-title":"BMC Gastroenterol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1111\/liv.13568","article-title":"Bacterial infection-triggered acute-on-chronic liver failure is associated with increased mortality","volume":"38","author":"Mucke","year":"2018","journal-title":"Liver Int."},{"key":"B100","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s40249-021-00830-7","article-title":"The role of prophylactic antibiotics in hepatitis B virus-related acute-on-chronic liver failure patients at risk of bacterial infection: a retrospective study","volume":"10","author":"Liu","year":"2021","journal-title":"Infect Dis Poverty."},{"key":"B101","doi-asserted-by":"publisher","first-page":"11493","DOI":"10.3748\/wjg.v21.i41.11493","article-title":"Immunomodulating effects of antibiotics used in the prophylaxis of bacterial infections in advanced cirrhosis","volume":"21","author":"Zapater","year":"2015","journal-title":"World J Gastroenterol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1126\/science.1214935","article-title":"Disease tolerance as a defense strategy","volume":"335","author":"Medzhitov","year":"2012","journal-title":"Science."},{"key":"B103","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/j.jhep.2007.01.034","article-title":"In vivo altered unfolded protein response and apoptosis in livers from lipopolysaccharide-challenged cirrhotic rats","volume":"46","author":"Tazi","year":"2007","journal-title":"J Hepatol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s12072-017-9798-x","article-title":"Gut-liver axis, cirrhosis and portal hypertension: the chicken and the egg","volume":"12","author":"Arab","year":"2018","journal-title":"Hepatol Int."},{"key":"B105","doi-asserted-by":"publisher","first-page":"5108781","DOI":"10.1155\/2018\/5108781","article-title":"Bacterial infection and predictors of mortality in patients with autoimmune liver disease-associated acute-on-chronic liver failure","volume":"2018","author":"Zhang","year":"2018","journal-title":"Can J Gastroenterol Hepatol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1097\/01.CCM.0000217961.75225.E9","article-title":"Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock","volume":"34","author":"Kumar","year":"2006","journal-title":"Crit Care Med."},{"key":"B107","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/liv.13981","article-title":"Invasive fungal infections amongst patients with acute-on-chronic liver failure at high risk for fungal infections","volume":"39","author":"Verma","year":"2019","journal-title":"Liver Int."},{"key":"B108","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.12998\/wjge.v7.i16.2204","article-title":"Incidence of infectious complications is associated with a high mortality in patients with hepatitis B virus-related acute-on-chronic liver failure","volume":"7","author":"Wang","year":"2019","journal-title":"World J Clin Cases."},{"key":"B109","doi-asserted-by":"publisher","first-page":"7485","DOI":"10.3748\/wjg.v26.i47.7485","article-title":"Invasive fungal infection before and after liver transplantation","volume":"26","author":"Ferrarese","year":"2020","journal-title":"World J Gastroenterol."},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.3390\/jof2030022","article-title":"Galactomannan and 1,3-beta-d-glucan testing for the diagnosis of invasive aspergillosis","volume":"2","author":"Lamoth","year":"2016","journal-title":"J Fungi (Basel)."},{"key":"B111","doi-asserted-by":"publisher","first-page":"ofaa453","DOI":"10.1093\/ofid\/ofaa453","article-title":"Prognostic role of bacterial and fungal infections in patients with liver cirrhosis with and without acute-on-chronic liver failure: a prospective 2-center study","volume":"7","author":"Bartoletti","year":"2020","journal-title":"Open Forum Infect Dis."},{"key":"B112","doi-asserted-by":"publisher","first-page":"199","DOI":"10.2139\/ssrn.3393722","article-title":"Fungal infection in acutely decompensated cirrhosis patients: value of model for end-stage liver disease score","volume":"13","author":"Habib","year":"2020","journal-title":"Gastroenterology Res."},{"key":"B113","doi-asserted-by":"publisher","first-page":"16037","DOI":"10.3748\/wjg.v20.i43.16037","article-title":"Potent antiviral therapy improves survival in acute on chronic liver failure due to hepatitis B virus reactivation","volume":"20","author":"Philips","year":"2014","journal-title":"World J Gastroenterol."},{"key":"B114","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1002\/hep.24109","article-title":"Tenofovir improves the outcome in patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure","volume":"53","author":"Garg","year":"2011","journal-title":"Hepatology."},{"key":"B115","doi-asserted-by":"publisher","first-page":"5802674","DOI":"10.1155\/2016\/5802674","article-title":"The comparative efficacy and safety of entecavir and lamivudine in patients with HBV-associated acute-on-chronic liver failure: a systematic review and meta-analysis","volume":"2016","author":"Yang","year":"2016","journal-title":"Gastroenterol Res Pract."},{"key":"B116","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1186\/s12879-021-06237-x","article-title":"Short-term and long-term safety and efficacy of tenofovir alafenamide, tenofovir disoproxil fumarate and entecavir treatment of acute-on-chronic liver failure associated with hepatitis B","volume":"21","author":"Li","year":"2021","journal-title":"BMC Infect Dis."},{"key":"B117","doi-asserted-by":"publisher","first-page":"e19164","DOI":"10.5812\/hepatmon.19164","article-title":"Entecavir versus Lamivudine therapy for patients with chronic hepatitis B-associated liver failure: a meta-analysis","volume":"14","author":"Zhang","year":"2014","journal-title":"Hepat Mon."},{"key":"B118","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12985-015-0323-3","article-title":"Initial combination anti-viral therapy with lamivudine and adefovir dipivoxil decreases short-term fatality rate of hepatitis-B-virus-related acute-on-chronic liver failure","volume":"12","author":"Yang","year":"2015","journal-title":"Virol J."},{"key":"B119","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12072-015-9675-4","article-title":"Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update","volume":"10","author":"Sarin","year":"2016","journal-title":"Hepatol Int."},{"key":"B120","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1002\/hep.29800","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance","volume":"67","author":"Terrault","year":"2018","journal-title":"Hepatology."},{"key":"B121","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"67","author":"EASL","year":"2017","journal-title":"J Hepatol"},{"key":"B122","doi-asserted-by":"publisher","first-page":"501","DOI":"10.7861\/clinmed.2020-0631","article-title":"Acute-on-chronic liver failure","volume":"20","author":"Kumar","year":"2020","journal-title":"Clin Med."},{"key":"B123","doi-asserted-by":"publisher","first-page":"688","DOI":"10.4254\/wjh.v6.i10.688","article-title":"Severe alcoholic hepatitis-current concepts, diagnosis and treatment options","volume":"6","author":"Kim","year":"2014","journal-title":"World J Hepatol."},{"key":"B124","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1002\/hep.21607","article-title":"The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids","volume":"45","author":"Louvet","year":"2007","journal-title":"Hepatology."},{"key":"B125","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.3390\/jcm10112338","article-title":"Day-4 Lille score is a good prognostic factor and early predictor in assessing therapy response in patients with liver cirrhosis and severe alcoholic hepatitis","volume":"10","author":"Foncea","year":"2021","journal-title":"J Clin Med."},{"key":"B126","doi-asserted-by":"publisher","first-page":"100176","DOI":"10.1016\/j.jhepr.2020.100176","article-title":"Acute-on-chronic liver failure: definitions, pathophysiology and principles of treatment","volume":"3","author":"Zaccherini","year":"2021","journal-title":"JHEP Rep."},{"key":"B127","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.2146\/ajhp140028","article-title":"Pharmacotherapy for alcoholic patients with alcoholic liver disease","volume":"71","author":"Vuittonet","year":"2014","journal-title":"Am J Health Syst Pharm."},{"key":"B128","doi-asserted-by":"publisher","first-page":"113","DOI":"10.14218\/JCTH.2016.00006","article-title":"Current management of alcoholic hepatitis and future therapies","volume":"4","author":"Saberi","year":"2016","journal-title":"J Clin Transl Hepatol."},{"key":"B129","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1002\/hep.24544","article-title":"Pentoxifylline improves nonalcoholic steatohepatitis: a randomized placebo-controlled trial","volume":"54","author":"Zein","year":"2011","journal-title":"Hepatology."},{"key":"B130","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1136\/gut.50.2.241","article-title":"Pentoxifylline downregulates profibrogenic cytokines and procollagen I expression in rat secondary biliary fibrosis","volume":"50","author":"Raetsch","year":"2002","journal-title":"Gut."},{"key":"B131","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1097\/MEG.0b013e3283435d76","article-title":"Prevention of hepatorenal syndrome in patients with cirrhosis and ascites: a pilot randomized control trial between pentoxifylline and placebo","volume":"23","author":"Tyagi","year":"2011","journal-title":"Eur J Gastroenterol Hepatol."},{"key":"B132","doi-asserted-by":"publisher","first-page":"810","DOI":"10.4103\/2141-9248.141562","article-title":"Pentoxifylline plus prednisolone versus pentoxifylline only for severe alcoholic hepatitis: a randomized controlled clinical trial","volume":"4","author":"De","year":"2014","journal-title":"Ann Med Health Sci Res."},{"key":"B133","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/hep.23258","article-title":"Alcoholic liver disease","volume":"51","author":"O'Shea","year":"2010","journal-title":"Hepatology."},{"key":"B134","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.jhep.2012.04.004","article-title":"EASL clinical practical guidelines: management of alcoholic liver disease","volume":"57","year":"2012","journal-title":"J Hepatol"},{"key":"B135","doi-asserted-by":"publisher","first-page":"30269","DOI":"10.3390\/ijms161226225","article-title":"Oxidative stress and inflammation in hepatic diseases: therapeutic possibilities of n-acetylcysteine","volume":"16","author":"de Andrade","year":"2015","journal-title":"Int J Mol Sci."},{"key":"B136","first-page":"8655","article-title":"N-acetylcysteine protects against liver injure induced by carbon tetrachloride via activation of the Nrf2\/HO-1 pathway","volume":"8","author":"Cai","year":"2015","journal-title":"Int J Clin Exp Pathol."},{"key":"B137","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1056\/NEJMoa1101214","article-title":"Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis","volume":"365","author":"Nguyen-Khac","year":"2011","journal-title":"N Engl J Med."},{"key":"B138","doi-asserted-by":"publisher","first-page":"3726","DOI":"10.1007\/s10620-020-06142-4","article-title":"A combination of n-acetylcysteine and prednisone has no benefit over prednisone alone in severe alcoholic hepatitis: a retrospective analysis","volume":"65","author":"Amjad","year":"2020","journal-title":"Dig Dis Sci."},{"key":"B139","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1016\/j.cgh.2018.01.040","article-title":"Efficacy of granulocyte colony-stimulating factor and n-acetylcysteine therapies in patients with severe alcoholic hepatitis","volume":"16","author":"Singh","year":"2018","journal-title":"Clin Gastroenterol Hepatol."},{"key":"B140","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.jhep.2010.05.030","article-title":"Enteral nutrition with or without N-acetylcysteine in the treatment of severe acute alcoholic hepatitis: a randomized multicenter controlled trial","volume":"53","author":"Moreno","year":"2010","journal-title":"J Hepatol."},{"key":"B141","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1002\/hep.25532","article-title":"Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: a prospective study","volume":"55","author":"Fernandez","year":"2012","journal-title":"Hepatology."},{"key":"B142","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1002\/hep.27941","article-title":"The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis: results of a randomized, controlled clinical trial","volume":"63","author":"Piano","year":"2016","journal-title":"Hepatology."},{"key":"B143","doi-asserted-by":"publisher","first-page":"4654","DOI":"10.3748\/wjg.v23.i25.4654","article-title":"Nosocomial spontaneous bacterial peritonitis antibiotic treatment in the era of multi-drug resistance pathogens: a systematic review","volume":"23","author":"Fiore","year":"2017","journal-title":"World J Gastroenterol."},{"key":"B144","doi-asserted-by":"publisher","first-page":"153","DOI":"10.2147\/HMER.S264231","article-title":"Albumin administration is efficacious in the management of patients with cirrhosis: a systematic review of the literature","volume":"12","author":"Zaccherini","year":"2020","journal-title":"Hepat Med."},{"key":"B145","doi-asserted-by":"publisher","first-page":"447","DOI":"10.14218\/JCTH.2020.00092","article-title":"Acute-on-chronic liver failure in a patient with candida endophthalmitis: a case report","volume":"9","author":"Cao","year":"2021","journal-title":"J Clin Transl Hepatol."},{"key":"B146","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1471-230X-7-2","article-title":"Invasive pulmonary aspergillosis in patients with decompensated cirrhosis: case series","volume":"7","author":"Prodanovic","year":"2007","journal-title":"BMC Gastroenterol."},{"key":"B147","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.7150\/ijms.6824","article-title":"Risk factors for invasive pulmonary aspergillosis and hospital mortality in acute-on-chronic liver failure patients: a retrospective-cohort study","volume":"10","author":"Chen","year":"2013","journal-title":"Int J Med Sci."},{"key":"B148","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s10096-010-1137-2","article-title":"Invasive pulmonary aspergillosis in patients with HBV-related liver failure","volume":"30","author":"Wang","year":"2011","journal-title":"Eur J Clin Microbiol Infect Dis."},{"key":"B149","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.jhep.2013.09.011","article-title":"Invasive aspergillosis in patients with severe alcoholic hepatitis","volume":"60","author":"Gustot","year":"2014","journal-title":"J Hepatol."},{"key":"B150","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1177\/030006051204000537","article-title":"Invasive pulmonary aspergillosis in patients with acute-on-chronic liver failure","volume":"40","author":"Wu","year":"2012","journal-title":"J Int Med Res."},{"key":"B151","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1093\/cid\/ciw444","article-title":"Executive summary: practice guidelines for the diagnosis and management of aspergillosis: 2016. Update by the Infectious Diseases Society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect Dis."},{"key":"B152","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ijantimicag.2014.05.019","article-title":"Voriconazole pharmacokinetics and exposure-response relationships: assessing the links between exposure, efficacy and toxicity","volume":"44","author":"Dolton","year":"2014","journal-title":"Int J Antimicrob Agents."},{"key":"B153","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1038\/s41598-018-19320-2","article-title":"Improving survival of acute-on-chronic liver failure patients complicated with invasive pulmonary aspergillosis","volume":"8","author":"Gao","year":"2018","journal-title":"Sci Rep."},{"key":"B154","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1097\/MCG.0000000000001568","article-title":"Treatment of severe acute on chronic liver failure: management of organ failures, investigational therapeutics, and the role of liver transplantation","volume":"55","author":"Vipani","year":"2021","journal-title":"J Clin Gastroenterol."},{"key":"B155","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s12967-018-1464-0","article-title":"Clinical performance of stem cell therapy in patients with acute-on-chronic liver failure: a systematic review and meta-analysis","volume":"16","author":"Xue","year":"2018","journal-title":"J Transl Med."},{"key":"B156","doi-asserted-by":"publisher","first-page":"100291","DOI":"10.1016\/j.jhepr.2021.100291","article-title":"A phase II study of human allogeneic liver-derived progenitor cell therapy for acute-on-chronic liver failure and acute decompensation","volume":"3","author":"Nevens","year":"2021","journal-title":"JHEP Rep."},{"key":"B157","doi-asserted-by":"publisher","first-page":"202","DOI":"10.2174\/1574888X15666200101124317","article-title":"A brief analysis of mesenchymal stem cells as biological drugs for the treatment of acute-on-chronic liver failure (ACLF): safety and potency","volume":"15","author":"Feng","year":"2020","journal-title":"Curr Stem Cell Res Ther."},{"key":"B158","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41536-019-0083-6","article-title":"Mesenchymal stem cell perspective: cell biology to clinical progress","volume":"4","author":"Pittenger","year":"2019","journal-title":"NPJ Regen Med."},{"key":"B159","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.livres.2021.03.003","article-title":"Mesenchymal stem cells therapy for acute liver failure: recent advances and future perspectives","volume":"5","author":"Luan","year":"2021","journal-title":"Liver Res."},{"key":"B160","doi-asserted-by":"publisher","first-page":"580","DOI":"10.3904\/kjim.2015.30.5.580","article-title":"Mesenchymal stem cell therapy for liver fibrosis","volume":"30","author":"Eom","year":"2015","journal-title":"Korean J Internal Med."},{"key":"B161","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1042\/CBI20110634","article-title":"Mesenchymal stem cells restore CCl4-induced liver injury by an antioxidative process","volume":"36","author":"Cho","year":"2012","journal-title":"Cell Biol Int."},{"key":"B162","doi-asserted-by":"publisher","first-page":"E206","DOI":"10.1111\/hepr.12204","article-title":"Canine mesenchymal stem cells show antioxidant properties against thioacetamide-induced liver injury in vitro and in vivo","volume":"44","author":"Quintanilha","year":"2014","journal-title":"Hepatol Res"},{"key":"B163","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1186\/s13287-021-02468-6","article-title":"Human umbilical cord-derived mesenchymal stem cells improve the function of liver in rats with acute-on-chronic liver failure via downregulating Notch and Stat1\/Stat3 signaling","volume":"12","author":"He","year":"2021","journal-title":"Stem Cell Res Ther."},{"key":"B164","doi-asserted-by":"publisher","first-page":"725","DOI":"10.5966\/sctm.2012-0034","article-title":"Human mesenchymal stem cell transfusion is safe and improves liver function in acute-on-chronic liver failure patients","volume":"1","author":"Shi","year":"2012","journal-title":"Stem Cells Transl Med."},{"key":"B165","doi-asserted-by":"publisher","first-page":"8660","DOI":"10.3748\/wjg.v20.i26.8660","article-title":"Outcomes of autologous bone marrow mononuclear cell transplantation in decompensated liver cirrhosis","volume":"20","author":"Bai","year":"2014","journal-title":"World J Gastroenterol."},{"key":"B166","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1053\/j.gastro.2011.11.027","article-title":"Granulocyte colony-stimulating factor mobilizes CD34(+) cells and improves survival of patients with acute-on-chronic liver failure","volume":"142","author":"Garg","year":"2012","journal-title":"Gastroenterology."},{"key":"B167","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1053\/j.gastro.2015.02.054","article-title":"Combination of granulocyte colony-stimulating factor and erythropoietin improves outcomes of patients with decompensated cirrhosis","volume":"148","author":"Kedarisetty","year":"2015","journal-title":"Gastroenterology."},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2021-BASL.10","article-title":"Granulocyte-Colony Stimulating Factor (G-CSF) to treat acute-on-chronic liver failure, a multicenter randomized trial (GRAFT study)","author":"Engelmann","year":"2021","journal-title":"J Hepatol."},{"key":"B169","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.jceh.2017.08.001","article-title":"Liver transplantation for acute on chronic liver failure","volume":"7","author":"Choudhary","year":"2017","journal-title":"J Clin Exp Hepatol."},{"key":"B170","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1053\/j.gastro.2008.02.028","article-title":"Indications for liver transplantation","volume":"134","author":"O'Leary","year":"2008","journal-title":"Gastroenterology."},{"key":"B171","doi-asserted-by":"publisher","first-page":"e544","DOI":"10.1097\/TXD.0000000000000984","article-title":"Outcomes of liver transplant recipients with acute-on-chronic liver failure based on EASL-CLIF consortium definition: a single-center study","volume":"6","author":"Agbim","year":"2020","journal-title":"Transplant Direct."},{"key":"B172","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.jhep.2019.10.013","article-title":"Effect of the clinical course of acute-on-chronic liver failure prior to liver transplantation on post-transplant survival","volume":"72","author":"Sundaram","year":"2020","journal-title":"J Hepatol."},{"key":"B173","doi-asserted-by":"publisher","first-page":"26","DOI":"10.21037\/tgh.2019.11.17","article-title":"Liver transplantation for alcoholic hepatitis","volume":"5","author":"Shipley","year":"2020","journal-title":"Transl Gastroenterol Hepatol."},{"key":"B174","doi-asserted-by":"publisher","first-page":"4423","DOI":"10.3748\/wjg.v21.i14.4423","article-title":"Six month abstinence rule for liver transplantation in severe alcoholic liver disease patients","volume":"21","author":"Obed","year":"2015","journal-title":"World J Gastroenterol."},{"key":"B175","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.3748\/wjg.v24.i26.2785","article-title":"Liver transplantation and alcoholic liver disease: History, controversies, and considerations","volume":"24","author":"Marroni","year":"2018","journal-title":"World J Gastroenterol."},{"key":"B176","first-page":"178","article-title":"Current management and future treatment of alcoholic hepatitis","volume":"16","author":"Mitchell","year":"2020","journal-title":"Gastroenterol Hepatol."},{"key":"B177","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1056\/NEJMoa1105703","article-title":"Early liver transplantation for severe alcoholic hepatitis","volume":"365","author":"Mathurin","year":"2011","journal-title":"N Engl J Med."},{"key":"B178","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1007\/s10620-020-06159-9","article-title":"Early liver transplantation for severe alcoholic hepatitis","volume":"65","author":"Mellinger","year":"2020","journal-title":"Dig Dis Sci."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.752875\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T05:00:57Z","timestamp":1636347657000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.752875\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,8]]},"references-count":178,"alternative-id":["10.3389\/fmed.2021.752875"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2021.752875","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,8]]},"article-number":"752875"}}